Why Weight Loss Slows on Mounjaro — and What Actually Helps

Step 1, Recognise what a slowdown actually is

If you weighed yourself weekly through the first month on Mounjaro, you probably saw a clear downward trend. Then, somewhere around weeks four to eight, or again after a dose increase settles in, the numbers may have barely shifted for a fortnight. That's frustrating, and you're not imagining it.

What's happening is partly metabolic adaptation. As your body loses weight, it needs fewer calories to function at rest. Your resting metabolic rate drops. This isn't a flaw in the medicine; it's the same biological process that makes every form of weight loss eventually plateau, and it was observed in the SURMOUNT-1 trial, where the rate of weight change slowed progressively even as participants continued to lose meaningful amounts over 72 weeks. The SURMOUNT-1 trial results, published in the New England Journal of Medicine, reported average body-weight reductions of around 20–21% at the 15 mg dose, but that loss accumulated over more than a year, not in a straight line. A temporary pause is not the same as a ceiling.

It also helps to know that water retention, hormonal cycles and day-to-day variation in gut contents can mask genuine fat loss on the scales for one to two weeks at a time. The trend over four to six weeks is a more reliable signal than any single weigh-in. If you want to understand why Mounjaro weight loss slows down and what that looks like in practice, that page covers the topic in depth. You can also read more about how weight loss with Mounjaro typically progresses if you want a broader picture.

Step 2 (Audit the factors that sit alongside the medicine

Tirzepatide reduces appetite and slows gastric emptying, but it works alongside a reduced-calorie diet and increased activity) that framing comes directly from its UK licence, not a marketing choice. When weight loss slows, it's worth an honest audit of what's changed in those surrounding factors.

Appetite suppression can quietly reduce itself over time between dose increases, meaning portion sizes creep back up without you noticing. Protein intake is worth particular attention: many people on GLP-1 medicines eat less overall, and if that reduction falls mainly on protein-rich foods, the body is more likely to lose muscle alongside fat, which further lowers resting metabolism. Aiming for adequate protein at each meal (your prescriber or a dietitian can give you a personal target) helps preserve muscle mass and supports continued progress.

Sleep and stress have a less obvious but real relationship with weight. Poor sleep raises ghrelin, a hormone that drives hunger, and elevated cortisol from chronic stress can promote fat retention even when calorie intake is controlled. None of this is a simple fix, but recognising these factors means you can address them rather than blame the medicine. For a broader look at why Mounjaro weight loss can slow, including specific lifestyle angles, there's a dedicated page that goes into more detail.

Step 3, Consider where you are in the dose schedule

Mounjaro's licensed schedule runs from 2.5 mg through 5, 7.5, 10, 12.5 and 15 mg, with each step usually taken for at least four weeks. The starter dose exists primarily to settle the digestive system, not to drive significant weight loss. Meaningful therapeutic effect typically builds as the dose rises.

If your weight loss has slowed and you're still on a lower dose, that context matters. A prescriber's job at a dose-review point is to assess whether moving up is clinically appropriate, and at nume, that review happens before every repeat, not just at the start. Evidence of your current dose's effect (weight records, photographs, how you're tolerating it) all feed into that clinical decision. You should never adjust your own dose; the prescriber makes that call based on your full picture.

If you're already at 15 mg and have been for several months with minimal change, NICE's guidance on tirzepatide (NICE technology appraisal TA1026) notes that continuing treatment should be reviewed if less than 5% weight loss has occurred after six months at the highest tolerated dose. That's a conversation for your prescriber, not a reason to stop without discussion. For questions about whether slowing is expected at a specific point in treatment, that page walks through the timing in more detail.

Step 4, Know when to contact your prescriber

A plateau of one to three weeks is almost always normal. Contact your prescriber if: the stall has lasted longer than four to six weeks with no obvious lifestyle explanation; you've developed new symptoms you hadn't noticed before; or you're considering stopping because you feel the medicine isn't working.

Stopping tirzepatide without clinical guidance can lead to rapid weight regain, this is a known pattern with GLP-1 medicines, and it's one of the reasons the overview of Mounjaro as a treatment stresses that it works best as part of an ongoing, clinically managed programme rather than a short course. Our prescribers at the nume clinical team review every repeat order; that's precisely the kind of check-in where a stall should be mentioned. If you're thinking about the cost side of ongoing treatment, the Mounjaro cost page sets out what private treatment actually involves financially. And when you're ready to speak to a prescriber, starting a free consultation is the first step.